July 15th 2025, 6:59pm
Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the rarity of their condition.
July 15th 2025, 5:08pm
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
July 15th 2025, 4:00pm
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
July 15th 2025, 3:00pm
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
July 15th 2025, 1:00pm
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
July 14th 2025, 9:00pm
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
July 14th 2025, 8:00pm
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
July 14th 2025, 7:00pm
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, according to Dr. Christina Poh.
July 14th 2025, 5:00pm
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
July 14th 2025, 4:00pm
In a candid interview with CURE, Terry Gillespie reflects on how her definition of survivorship has evolved from her lung cancer diagnosis to present day.
Coping With a Rare Cancer Diagnosis, Like GIST
Refining Treatment Approaches and Advancements in High-Risk Melanoma
Celebrating My Clean Bill of Health After Cancer
Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer